This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1991.
Company Filing History:
Years Active: 1991
Title: Michel Eichelbaum: Innovator in Antitumor Compositions
Introduction
Michel Eichelbaum is a notable inventor based in Ludwigsburg, Germany. He has made significant contributions to the field of oncology through his innovative research and patenting efforts. His work focuses on developing active compounds for the treatment of tumors, showcasing his commitment to advancing medical science.
Latest Patents
Michel Eichelbaum holds a patent for "Active compounds for use in the treatment of tumors." This patent details antitumor compositions and methods in which a cancerostatic agent is administered alongside an effective amount of (+)-verapamil, (+)-gallopamil, (+)-devapamil, and/or (+)-emopamil. These compounds are designed to reinforce the antitumor action of the cancerostatic agent, providing a promising approach to cancer treatment. He has 1 patent to his name.
Career Highlights
Eichelbaum is associated with BASF Aktiengesellschaft, a leading global chemical company. His role at BASF has allowed him to collaborate with other experts in the field, further enhancing his research capabilities and contributions to cancer treatment.
Collaborations
Some of his notable coworkers include Rolf Kretzschmar and Erich Schlick. Their collaborative efforts have likely played a role in the development of innovative solutions in the field of oncology.
Conclusion
Michel Eichelbaum's work in developing antitumor compositions represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the medical field.